A detailed history of Dean Investment Associates, LLC transactions in Amgen Inc stock. As of the latest transaction made, Dean Investment Associates, LLC holds 15,715 shares of AMGN stock, worth $5.02 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
15,715
Previous 17,170 8.47%
Holding current value
$5.02 Million
Previous $4.88 Million 0.59%
% of portfolio
0.7%
Previous 0.67%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $382,301 - $464,596
-1,455 Reduced 8.47%
15,715 $4.91 Million
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $1.85 Million - $2.23 Million
-6,864 Reduced 28.56%
17,170 $4.88 Million
Q4 2023

Feb 09, 2024

SELL
$255.7 - $288.46 $1.88 Million - $2.12 Million
-7,359 Reduced 23.44%
24,034 $6.92 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $33,016 - $40,990
-151 Reduced 0.48%
31,393 $8.44 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $7,713 - $9,121
36 Added 0.11%
31,544 $7 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $1.14 Million - $1.39 Million
5,038 Added 19.03%
31,508 $7.62 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $502,720 - $638,766
2,195 Added 9.04%
26,470 $6.95 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $2.56 Million - $2.88 Million
11,384 Added 88.31%
24,275 $5.47 Million
Q2 2022

Aug 18, 2022

SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 0.23%
12,891 $3.14 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $71,262 - $78,835
325 Added 2.58%
12,921 $3.13 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $68,215 - $78,066
-343 Reduced 2.65%
12,596 $2.83 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $48,397 - $56,703
228 Added 1.79%
12,939 $2.75 Million
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $29,431 - $32,651
126 Added 1.0%
12,711 $3.1 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $109,704 - $130,638
-507 Reduced 3.87%
12,585 $2.89 Million
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $40,829 - $45,405
-174 Reduced 1.31%
13,092 $3.33 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $833,966 - $1.02 Million
-4,216 Reduced 24.12%
13,266 $3.13 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $114,446 - $151,787
-628 Reduced 3.47%
17,482 $3.54 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $46,356 - $59,584
-245 Reduced 1.33%
18,110 $4.37 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $124,488 - $149,163
715 Added 4.05%
18,355 $3.55 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $61,678 - $72,301
370 Added 2.14%
17,640 $3.25 Million
Q1 2019

May 08, 2019

BUY
$180.87 - $203.88 $72,528 - $81,755
401 Added 2.38%
17,270 $3.28 Million
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $296,679 - $346,319
1,663 Added 10.94%
16,869 $3.28 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $278,861 - $314,379
1,505 Added 10.98%
15,206 $3.15 Million
Q2 2018

Aug 08, 2018

SELL
$166.05 - $186.51 $45,829 - $51,476
-276 Reduced 1.97%
13,701 $2.53 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $404,598 - $472,824
2,388 Added 20.61%
13,977 $2.38 Million
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $56,375 - $62,989
334 Added 2.97%
11,589 $2.02 Million
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $1.88 Million - $2.15 Million
11,255
11,255 $2.1 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Dean Investment Associates, LLC Portfolio

Follow Dean Investment Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dean Investment Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dean Investment Associates, LLC with notifications on news.